Tag: #prv

Articles related to prv

industry

Ultragenyx Agrees to Sell FDA Rare Pediatric-Disease Priority Review Voucher for $203 Million

Ultragenyx said it agreed to sell a rare pediatric disease priority review voucher tied to gene therapy FAYUVI for $203M, its second PRV sale this month.

$RARE, #biotech, #ultragenyx, #prv, #raredisease